The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

ImmunoGen Inc

Nasdaq: IMGN
Last

(U.S.) $3.61

Today's change-0.05 -1.37%
Updated March 24 4:00 PM EDT. Delayed by at least 15 minutes.
 

ImmunoGen Inc

Nasdaq: IMGN
Last

(U.S.) $3.61

Today's change-0.05 -1.37%
Updated March 24 4:00 PM EDT. Delayed by at least 15 minutes.

ImmunoGen Inc down (U.S.)$0.05

ImmunoGen Inc closed lower Friday, dropping (U.S.)$0.05 or 1.37% to (U.S.)$3.61. Over the last five days, shares have gained 0.84% and 76.96% year to date. Shares have underperformed the S&P 500 by 69.14% during the last year.

Key company metrics

  • Open(U.S.) $3.67
  • Previous close(U.S.) $3.66
  • High(U.S.) $3.68
  • Low(U.S.) $3.52
  • Bid / Ask(U.S.) $3.16 / (U.S.) $3.66
  • YTD % change+76.96%
  • Volume1,266,913
  • Average volume (10-day)2,296,411
  • Average volume (1-month)2,207,364
  • Average volume (3-month)2,005,028
  • 52-week range(U.S.) $1.51 to (U.S.) $9.78
  • Beta2.21
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.80
Updated March 24 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue1481815
Total other revenue--------
Total revenue1481815
Gross profit--------
Total cost of revenue--------
Total operating expense42464643
Selling / general / administrative9988
Research & development34333835
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)04----
Other operating expenses, total--------
Operating income-29-39-28-29
Interest income (expense), net non-operating-1-1----
Gain (loss) on sale of assets--------
Other--------
Income before tax-34-45-33-34
Income after tax-34-45-33-34
Income tax, total--------
Net income-34-45-33-34
Total adjustments to net income--0----
Net income before extra. items-34-45-33-34
Minority interest--0----
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-34-45-33-34
Inc. avail. to common incl. extra. items-34-45-33-34
Diluted net income-34-45-33-34
Dilution adjustment--------
Diluted weighted average shares87878787
Diluted EPS excluding extraordinary itemsvalue per share-0.39-0.51-0.38-0.39
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.39-0.47-0.38-0.39